Abstract
We study a statistical lattice model of a mitigated epidemic. The level of mitigation, defined by measures to slow down the spread of the infection, is characterized by the infection transmissivity. It is determined by people’s mobility, frequency of contacts, and probability to catch the virus from a contact. In the absence of testing the infected people are isolated for a finite period of time during which they are symptomatic. In the presence of testing, people become isolated a soon as they are tested positive. We compute time dependence of daily new infections as function of transmissivity, initial infection, and testing. The duration of the epidemic increases rapidly with the increased level of mitigation while the number of people falling sick daily decreases. Testing, regardless of the level, has little effect on the duration of the epidemic. The total number of people who contract the disease over the lifetime of the epidemic depends weakly on its duration. It does not change significantly for the homogeneous testing of the population at the level below 10% daily.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Authors' research is supported by the U.S. Department of Energy, Office of Science, DOE Grant DE-FG02-93ER45487. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the DOE.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This work is a computer simulation.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the data related to this article are available from the authors.
